SCHEMBL16570346

SCHEMBL16570346

CCS(=O)(=O)N(CCO)c1ccccc1Cn1ccc2cnc(Nc3ccc(N4CCN[C@H](C)C4)cc3)nc21

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ STAT6 P42226 10/20 0.47
▸ ADRA2A P08913 1/20 0.43
▸ ADRA2B P18089 1/20 0.43
▸ ADRA2C P18825 1/20 0.43
▸ WEE1 P30291 2/20 0.43
▸ FGFR4 P22455 2/20 0.41
▸ FGFR1 P11362 1/20 0.41
▸ FGFR2 P21802 1/20 0.41
▸ FGFR3 P22607 1/20 0.41
▸ JAK3 P52333 3/20 0.40
▸ JAK2 O60674 3/20 0.39
▸ BRD4 O60885 3/20 0.39
▸ JAK1 P23458 2/20 0.39
▸ BRD2 P25440 2/20 0.39
▸ BRD3 Q15059 2/20 0.39
▸ BRDT Q58F21 2/20 0.39
▸ CDK4 P11802 1/20 0.39
▸ CDK6 Q00534 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17958763 1.00 STAT6 (0.47) STAT6ADRA2AADRA2BADRA2CWEE1
SCHEMBL16580997 0.94 STAT6 (0.48) STAT6ADRA2AADRA2BADRA2CWEE1
SCHEMBL16580723 0.86 STAT6 (0.51) STAT6ADRA2AADRA2BADRA2CWEE1
SCHEMBL16570999 0.86 STAT6 (0.51) STAT6ADRA2AADRA2BADRA2CWEE1
SCHEMBL16569916 0.86 STAT6 (0.51) STAT6ADRA2AADRA2BADRA2CWEE1
SCHEMBL16570185 0.86 STAT6 (0.45) STAT6ADRA2AADRA2BADRA2CWEE1
SCHEMBL16580765 0.86 STAT6 (0.45) STAT6ADRA2AADRA2BADRA2CWEE1
SCHEMBL16571177 0.84 STAT6 (0.49) STAT6ADRA2AADRA2BADRA2CWEE1
SCHEMBL16570779 0.84 STAT6 (0.51) STAT6ADRA2AADRA2BADRA2CWEE1
SCHEMBL16580863 0.84 STAT6 (0.55) STAT6FGFR4JAK3JAK2BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160222014-A1 COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS ASANA BIOSCIENCES, LLC (US) 2016-08-04 — — US claimed
WO-2015038417-A1 COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS ASANA BIOSCIENCES, LLC (US) 2015-03-19 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160222014-A1 COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS SRC, PTK2, FYN STAT6 103/4885ADRA2A 3261/4885ADRA2B 3569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback